Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP515184.RAKGpAZHK8V5f4VL7mSeJ9_CuNTF_9a77PVVVQt7cg_Qk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP515184.RAKGpAZHK8V5f4VL7mSeJ9_CuNTF_9a77PVVVQt7cg_Qk130_assertion type Assertion NP515184.RAKGpAZHK8V5f4VL7mSeJ9_CuNTF_9a77PVVVQt7cg_Qk130_head.
- NP515184.RAKGpAZHK8V5f4VL7mSeJ9_CuNTF_9a77PVVVQt7cg_Qk130_assertion description "[Four hundred sixty-seven patients who were diagnosed as having de novo MDS at the Division of Hematology, University of Pavia (Pavia, Italy), between 1992 and 2002, were evaluated retrospectively for clinical and hematologic features at diagnosis, overall survival (OS), and progression to leukemia (leukemia-free survival).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515184.RAKGpAZHK8V5f4VL7mSeJ9_CuNTF_9a77PVVVQt7cg_Qk130_provenance.
- NP515184.RAKGpAZHK8V5f4VL7mSeJ9_CuNTF_9a77PVVVQt7cg_Qk130_assertion evidence source_evidence_literature NP515184.RAKGpAZHK8V5f4VL7mSeJ9_CuNTF_9a77PVVVQt7cg_Qk130_provenance.
- NP515184.RAKGpAZHK8V5f4VL7mSeJ9_CuNTF_9a77PVVVQt7cg_Qk130_assertion SIO_000772 16186598 NP515184.RAKGpAZHK8V5f4VL7mSeJ9_CuNTF_9a77PVVVQt7cg_Qk130_provenance.
- NP515184.RAKGpAZHK8V5f4VL7mSeJ9_CuNTF_9a77PVVVQt7cg_Qk130_assertion wasDerivedFrom befree-2016 NP515184.RAKGpAZHK8V5f4VL7mSeJ9_CuNTF_9a77PVVVQt7cg_Qk130_provenance.
- NP515184.RAKGpAZHK8V5f4VL7mSeJ9_CuNTF_9a77PVVVQt7cg_Qk130_assertion wasGeneratedBy ECO_0000203 NP515184.RAKGpAZHK8V5f4VL7mSeJ9_CuNTF_9a77PVVVQt7cg_Qk130_provenance.